ORBIMED ADVISORS LLC Diversified Active

Location: New York, NY

CIK: 0001055951 · Show all filings

Period: Q2 2019 (← Previous) (Next →)

Filing Date: Aug 14, 2019

Total Value: $6.457B (100.0% shares, 0.0% debt)

Holdings (128)

ASND ASCENDIS PHARMA A S 6.9%
Value $443M Shares 3,846,673 Est. Cost Unrealized
TRICIDA INC 6.8%
Value $439M Shares 11,114,280 Est. Cost Unrealized
BSX BOSTON SCIENTIFIC CORP 4.5%
Value $290M Shares 6,752,500 Est. Cost Unrealized
ALEXION PHARMACEUTICALS INC 3.9%
Value $252M Shares 1,926,085 Est. Cost Unrealized
ALEC ALECTOR INC 3.9%
Value $250M Shares 13,182,329 Est. Cost Unrealized
MRK MERCK & CO INC 3.3%
Value $216M Shares 2,570,100 Est. Cost Unrealized
PREVAIL THERAPEUTICS INC 2.8%
Value $182M Shares 13,822,463 Est. Cost Unrealized
VRTX VERTEX PHARMACEUTICALS INC 2.8%
Value $178M Shares 973,300 Est. Cost Unrealized
NBIX NEUROCRINE BIOSCIENCES INC 2.4%
Value $155M Shares 1,833,200 Est. Cost Unrealized
IOVA IOVANCE BIOTHERAPEUTICS INC 2.1%
Value $136M Shares 5,548,326 Est. Cost Unrealized
TMO THERMO FISHER SCIENTIFIC INC 2.1%
Value $136M Shares 462,800 Est. Cost Unrealized
EW EDWARDS LIFESCIENCES CORP 2.0%
Value $132M Shares 715,000 Est. Cost Unrealized
SRPT SAREPTA THERAPEUTICS INC 1.9%
Value $126M Shares 828,400 Est. Cost Unrealized
WRIGHT MED GROUP N V 1.9%
Value $125M Shares 4,187,799 Est. Cost Unrealized
ISRG INTUITIVE SURGICAL INC 1.7%
Value $110M Shares 210,300 Est. Cost Unrealized
TURNING POINT THERAPEUTICS I 1.6%
Value $104M Shares 2,567,550 Est. Cost Unrealized
ELV ANTHEM INC 1.6%
Value $102M Shares 361,600 Est. Cost Unrealized
BHC BAUSCH HEALTH COS INC 1.5%
Value $94.34M Shares 3,740,700 Est. Cost Unrealized
PTCT PTC THERAPEUTICS INC 1.5%
Value $94.04M Shares 2,089,700 Est. Cost Unrealized
INSP INSPIRE MED SYS INC 1.4%
Value $89.22M Shares 1,471,000 Est. Cost Unrealized
NTRA NATERA INC 1.4%
Value $88.93M Shares 3,224,328 Est. Cost Unrealized
LOGICBIO THERAPEUTICS INC 1.3%
Value $84.07M Shares 6,466,783 Est. Cost Unrealized
EXEL EXELIXIS INC 1.3%
Value $83.62M Shares 3,912,900 Est. Cost Unrealized
AVEDRO INC 1.3%
Value $83.28M Shares 4,240,128 Est. Cost Unrealized
DECIPHERA PHARMACEUTICALS IN 1.3%
Value $81.59M Shares 3,618,171 Est. Cost Unrealized
ABT ABBOTT LABS 1.2%
Value $78.89M Shares 938,000 Est. Cost Unrealized
EHTH EHEALTH INC 1.2%
Value $78.33M Shares 909,814 Est. Cost Unrealized
ATHENEX INC 1.2%
Value $76.03M Shares 3,840,130 Est. Cost Unrealized
SYNTHORX INC 1.1%
Value $71.82M Shares 5,316,355 Est. Cost Unrealized
QURE UNIQURE NV 1.1%
Value $70.16M Shares 897,800 Est. Cost Unrealized
MGTX MEIRAGTX HOLDINGS PLC 1.1%
Value $69.54M Shares 2,586,951 Est. Cost Unrealized
REGN REGENERON PHARMACEUTICALS 1.0%
Value $67.55M Shares 215,800 Est. Cost Unrealized
A AGILENT TECHNOLOGIES INC 1.0%
Value $66.69M Shares 893,200 Est. Cost Unrealized
AUDENTES THERAPEUTICS INC 1.0%
Value $64.86M Shares 1,713,069 Est. Cost Unrealized
BMY BRISTOL MYERS SQUIBB CO 0.9%
Value $61.01M Shares 1,345,200 Est. Cost Unrealized
ARVN ARVINAS INC 0.9%
Value $58.91M Shares 2,678,810 Est. Cost Unrealized
PRINCIPIA BIOPHARMA INC 0.8%
Value $53.29M Shares 1,605,713 Est. Cost Unrealized
ILMN ILLUMINA INC 0.8%
Value $51.62M Shares 140,200 Est. Cost Unrealized
CRNX CRINETICS PHARMACEUTICALS IN 0.8%
Value $50.98M Shares 2,039,282 Est. Cost Unrealized
RESTORBIO INC 0.8%
Value $49.27M Shares 4,830,387 Est. Cost Unrealized
MYOKARDIA INC 0.7%
Value $47.9M Shares 955,300 Est. Cost Unrealized
APLS APELLIS PHARMACEUTICALS INC 0.7%
Value $46.21M Shares 1,823,700 Est. Cost Unrealized
VRAYQ VIEWRAY INC 0.7%
Value $45.36M Shares 5,149,019 Est. Cost Unrealized
ARGX ARGENX SE 0.7%
Value $43.95M Shares 310,400 Est. Cost Unrealized
ZLAB ZAI LAB LTD 0.6%
Value $40.76M Shares 1,169,000 Est. Cost Unrealized
NEXTCURE INC 0.6%
Value $40.61M Shares 2,711,013 Est. Cost Unrealized
CI CIGNA CORP NEW 0.6%
Value $39.8M Shares 252,600 Est. Cost Unrealized
DXCM DEXCOM INC 0.6%
Value $39.39M Shares 262,900 Est. Cost Unrealized
TNDM TANDEM DIABETES CARE INC 0.6%
Value $36.83M Shares 570,790 Est. Cost Unrealized
PRTA PROTHENA CORP PLC 0.5%
Value $32.4M Shares 3,065,278 Est. Cost Unrealized
HARPOON THERAPEUTICS INC 0.5%
Value $31.8M Shares 2,446,409 Est. Cost Unrealized
CDNA CAREDX INC 0.5%
Value $29.79M Shares 827,600 Est. Cost Unrealized
OBSEVA SA 0.5%
Value $29.47M Shares 2,605,531 Est. Cost Unrealized
SPY SPDR S&P 500 ETF TR 0.5%
Value $29.3M Shares 100,000 Est. Cost Unrealized
CLOVIS ONCOLOGY INC 0.4%
Value $28.45M Shares 1,913,234 Est. Cost Unrealized
XTNT XTANT MED HLDGS INC 0.4%
Value $27.62M Shares 9,207,012 Est. Cost Unrealized
GILD GILEAD SCIENCES INC 0.4%
Value $27.13M Shares 401,600 Est. Cost Unrealized
MYLAN N V 0.4%
Value $26.15M Shares 1,373,305 Est. Cost Unrealized
KRYS KRYSTAL BIOTECH INC 0.4%
Value $25.85M Shares 642,006 Est. Cost Unrealized
ENDO INTL PLC 0.4%
Value $25.4M Shares 6,165,464 Est. Cost Unrealized
CRVS CORVUS PHARMACEUTICALS INC 0.4%
Value $24.56M Shares 6,565,685 Est. Cost Unrealized
ADVERUM BIOTECHNOLOGIES INC 0.4%
Value $23.31M Shares 1,960,200 Est. Cost Unrealized
AUPH AURINIA PHARMACEUTICALS INC 0.4%
Value $23.23M Shares 3,531,002 Est. Cost Unrealized
BMY BRISTOL MYERS SQUIBB CO 0.4%
Value $22.68M Shares 500,000 Est. Cost Unrealized
SPARK THERAPEUTICS INC 0.3%
Value $22.51M Shares 219,900 Est. Cost Unrealized
AMGN AMGEN INC 0.3%
Value $22.5M Shares 122,100 Est. Cost Unrealized
GNFTY GENFIT S A 0.3%
Value $22.23M Shares 1,125,607 Est. Cost Unrealized
KALA PHARMACEUTICALS INC 0.3%
Value $22M Shares 3,447,840 Est. Cost Unrealized
ALC ALCON INC 0.3%
Value $21.68M Shares 351,380 Est. Cost Unrealized
BIIB BIOGEN INC 0.3%
Value $20.51M Shares 87,700 Est. Cost Unrealized
SIBN SI BONE INC 0.3%
Value $20.04M Shares 985,368 Est. Cost Unrealized
KARYOPHARM THERAPEUTICS INC 0.3%
Value $18.86M Shares 3,148,475 Est. Cost Unrealized
SYNLOGIC INC 0.3%
Value $18.47M Shares 2,029,996 Est. Cost Unrealized
TAK TAKEDA PHARMACEUTICAL CO LTD 0.3%
Value $17.7M Shares 1,000,000 Est. Cost Unrealized
RYTM RHYTHM PHARMACEUTICALS INC 0.3%
Value $17.32M Shares 787,300 Est. Cost Unrealized
VERRICA PHARMACEUTICALS INC 0.3%
Value $17.19M Shares 1,479,733 Est. Cost Unrealized
NVO NOVO-NORDISK A S 0.3%
Value $16.84M Shares 330,000 Est. Cost Unrealized
SVA SINOVAC BIOTECH LTD 0.3%
Value $16.61M Shares 2,839,500 Est. Cost Unrealized
ALPINE IMMUNE SCIENCES INC 0.2%
Value $15.46M Shares 3,670,955 Est. Cost Unrealized
AEGLEA BIOTHERAPEUTICS INC 0.2%
Value $14.83M Shares 2,165,524 Est. Cost Unrealized
ABBV ABBVIE INC 0.2%
Value $14.54M Shares 200,000 Est. Cost Unrealized
X4 PHARMACEUTICALS INC 0.2%
Value $14.05M Shares 936,493 Est. Cost Unrealized
AMARIN CORP PLC 0.2%
Value $13.91M Shares 717,600 Est. Cost Unrealized
TAK TAKEDA PHARMACEUTICAL CO LTD 0.2%
Value $13.28M Shares 750,000 Est. Cost Unrealized
PRQR PROQR THRAPEUTICS N V 0.2%
Value $12.58M Shares 1,382,502 Est. Cost Unrealized
FOAMIX PHARMACEUTICALS LTD 0.2%
Value $12.37M Shares 5,195,330 Est. Cost Unrealized
IMMUNOMEDICS INC 0.2%
Value $11.35M Shares 818,200 Est. Cost Unrealized
NABRIVA THERAPEUTICS PLC 0.2%
Value $11.29M Shares 4,644,600 Est. Cost Unrealized
SYK STRYKER CORP 0.2%
Value $11.1M Shares 54,000 Est. Cost Unrealized
ARQULE INC 0.2%
Value $11.01M Shares 1,000,000 Est. Cost Unrealized
SCPHARMACEUTICALS INC 0.2%
Value $10.88M Shares 3,409,865 Est. Cost Unrealized
PFE PFIZER INC 0.2%
Value $10.83M Shares 250,000 Est. Cost Unrealized
CONSTELLATION PHARMCETICLS I 0.2%
Value $10.26M Shares 835,842 Est. Cost Unrealized
REATA PHARMACEUTICALS INC 0.1%
Value $9.435M Shares 100,000 Est. Cost Unrealized
PSNL PERSONALIS INC 0.1%
Value $8.145M Shares 300,000 Est. Cost Unrealized
PBYI PUMA BIOTECHNOLOGY INC 0.1%
Value $7.934M Shares 624,249 Est. Cost Unrealized
MERSANA THERAPEUTICS INC 0.1%
Value $7.659M Shares 1,891,119 Est. Cost Unrealized
ASSEMBLY BIOSCIENCES INC 0.1%
Value $7.063M Shares 523,600 Est. Cost Unrealized
GILD GILEAD SCIENCES INC 0.1%
Value $6.756M Shares 100,000 Est. Cost Unrealized
FOLD AMICUS THERAPEUTICS INC 0.1%
Value $6.468M Shares 518,309 Est. Cost Unrealized
ARENA PHARMACEUTICALS INC 0.1%
Value $6.449M Shares 110,000 Est. Cost Unrealized
BMRN BIOMARIN PHARMACEUTICAL INC 0.1%
Value $6.424M Shares 75,000 Est. Cost Unrealized
BMRN BIOMARIN PHARMACEUTICAL INC 0.1%
Value $6.424M Shares 75,000 Est. Cost Unrealized
VERONA PHARMA PLC 0.1%
Value $6.377M Shares 1,250,396 Est. Cost Unrealized
XENE XENON PHARMACEUTICALS INC 0.1%
Value $6.259M Shares 634,812 Est. Cost Unrealized
SPRO SPERO THERAPEUTICS INC 0.1%
Value $5.841M Shares 507,471 Est. Cost Unrealized
ADPT ADAPTIVE BIOTECHNOLOGIES COR 0.1%
Value $5.796M Shares 120,000 Est. Cost Unrealized
MEDICINES CO 0.1%
Value $5.526M Shares 151,515 Est. Cost Unrealized
ADAPY ADAPTIMMUNE THERAPEUTICS PLC 0.1%
Value $5.43M Shares 1,350,655 Est. Cost Unrealized
NTLA INTELLIA THERAPEUTICS INC 0.1%
Value $5.363M Shares 327,600 Est. Cost Unrealized
SELECTA BIOSCIENCES INC 0.1%
Value $5.154M Shares 2,879,064 Est. Cost Unrealized
RARE ULTRAGENYX PHARMACEUTICAL IN 0.1%
Value $5.055M Shares 79,607 Est. Cost Unrealized
AERPIO PHARMACEUTICALS INC 0.1%
Value $4.726M Shares 5,193,946 Est. Cost Unrealized
CTI BIOPHARMA CORP 0.1%
Value $4.297M Shares 5,000,000 Est. Cost Unrealized
MENLO THERAPEUTICS INC 0.1%
Value $4.035M Shares 673,700 Est. Cost Unrealized
STOK STOKE THERAPEUTICS INC 0.1%
Value $3.792M Shares 130,000 Est. Cost Unrealized
NOVUS THERAPEUTICS INC 0.0%
Value $3.215M Shares 3,183,314 Est. Cost Unrealized
REALM THERAPEUTICS PLC 0.0%
Value $2.87M Shares 1,021,484 Est. Cost Unrealized
ACAD ACADIA PHARMACEUTICALS INC 0.0%
Value $2.724M Shares 101,900 Est. Cost Unrealized
DYNAVAX TECHNOLOGIES CORP 0.0%
Value $2.328M Shares 583,500 Est. Cost Unrealized
SNDX SYNDAX PHARMACEUTICALS INC 0.0%
Value $1.974M Shares 212,000 Est. Cost Unrealized
APLS APELLIS PHARMACEUTICALS INC 0.0%
Value $1.901M Shares 75,000 Est. Cost Unrealized
AVROBIO INC 0.0%
Value $1.724M Shares 106,000 Est. Cost Unrealized
MARINUS PHARMACEUTICALS INC 0.0%
Value $1.652M Shares 398,101 Est. Cost Unrealized
NUVECTRA CORP 0.0%
Value $1.173M Shares 350,000 Est. Cost Unrealized
FLEXION THERAPEUTICS INC 0.0%
Value $1.106M Shares 89,919 Est. Cost Unrealized
BIOLINERX LTD 0.0%
Value $379K Shares 1,038,600 Est. Cost Unrealized
MEDIGUS LTD 0.0%
Value $37,000 Shares 15,000 Est. Cost Unrealized